Your Complete Mounjaro to Wegovy Transition Roadmap
Understanding Mounjaro to Wegovy Dose Conversion Chart Fundamentals
The reality of transitioning from Mounjaro (tirzepatide) to Wegovy (semaglutide) often surprises patients expecting direct dose equivalencies. Unlike switching between similar medications, this mounjaro to wegovy dose conversion chart reveals that most prescribers recommend restarting Wegovy's established escalation protocol from the 0.25mg starter dose. This approach ensures optimal tolerability and effectiveness, regardless of whether you were taking 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg Mounjaro. The two medications work through different mechanisms – Mounjaro targets both GIP and GLP-1 receptors, while Wegovy focuses exclusively on GLP-1 receptors.
This restart approach means your monthly cost journey follows Wegovy's structured 16-week escalation, beginning at £79.99 for the first month. Planning your transition requires understanding both the clinical rationale and financial commitment across the full dose escalation period. Your prescriber will determine the safest transition timeline, which may include a washout period between stopping Mounjaro and beginning Wegovy. This mounjaro to wegovy dose conversion chart approach prioritises safety and long-term success over attempting complex dose equivalencies that lack clinical validation.
Monthly Cost Breakdown for Your Mounjaro to Wegovy Conversion
Your mounjaro to wegovy dose conversion chart journey involves predictable monthly costs across the 16-week escalation period. Month one (weeks 1-4) costs £79.99 for the 0.25mg starter dose, applying the FIRST40 discount code at checkout. Month two (weeks 5-8) increases to £94.99 for the 0.5mg dose, while month three (weeks 9-12) costs £99.99 for the 1mg strength. The fourth month (weeks 13-16) reaches £139.99 for the 1.7mg dose before settling into the maintenance 2.4mg dose at £209.99 monthly from week 17 onwards.
Returning customers benefit from the DOSE25 discount code applied at checkout, maintaining these competitive prices throughout their treatment journey. Annual maintenance cost at the 2.4mg dose totals approximately £2,519.88, providing clear budgeting clarity for long-term weight management planning. Our bundle options offer convenience advantages, such as the Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment without monthly reordering. This transparent pricing structure eliminates uncertainty from your mounjaro to wegovy dose conversion chart planning, allowing focus on your health goals rather than cost surprises.
Clinical Evidence Supporting Your Mounjaro to Wegovy Transition
The STEP clinical trial programme, including the landmark study by Wilding et al., NEJM, 2021, demonstrated Wegovy's effectiveness in supporting weight management alongside reduced-calorie diet and increased physical activity. In clinical trials, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo in the STEP 1 trial. The STEP 5 trial confirmed sustained weight loss of approximately 15.2% at two years, supporting the long-term value proposition reflected in this mounjaro to wegovy dose conversion chart.
Recent SELECT trial data revealed a 20% reduction in major cardiovascular events (HR 0.80) among patients taking Wegovy, demonstrating benefits beyond weight management. These clinical outcomes support the structured dose escalation approach recommended in most mounjaro to wegovy dose conversion chart protocols, ensuring patients achieve optimal therapeutic benefits while maintaining tolerability throughout the transition process.
How Wegovy Works During Your Conversion Process
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management. This prescription-only medicine works by reducing appetite and promoting feelings of fullness after smaller meals, potentially reducing food cravings through its action on brain appetite centres. Unlike Mounjaro's dual GIP and GLP-1 receptor targeting, Wegovy focuses exclusively on GLP-1 pathways, which explains why direct dose conversions aren't clinically recommended. The once-weekly FlexTouch pen delivery system ensures consistent medication levels throughout your treatment week. Understanding this mechanism helps explain why your mounjaro to wegovy dose conversion chart requires restarting the escalation process rather than attempting equivalent dosing from your previous Mounjaro strength.
Your EverydayMeds Ordering Process for Wegovy
Beginning your mounjaro to wegovy dose conversion chart journey through EverydayMeds starts with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring safe transition protocols between your Mounjaro and Wegovy treatments. Once approved, your prescription ships via next-day delivery using temperature-controlled cold-chain logistics, maintaining the medication's integrity from our GPhC-registered pharmacy (#9012878) to your door. The assessment specifically addresses your transition from Mounjaro, ensuring appropriate washout periods and monitoring protocols. Your prescriber provides detailed guidance on timing your switch and managing the dose escalation process safely.
Storage and Practical Considerations for Your Transition
Wegovy requires refrigeration at 2-8°C before first use, though it maintains stability for up to 6 weeks at room temperature below 30°C once removed from the fridge – a significant advantage over Mounjaro's 21-day room temperature limit. The FlexTouch pen system delivers precise doses through a simple injection process, with each pen containing four doses for your weekly injections. Your mounjaro to wegovy dose conversion chart timeline cannot skip escalation steps, as each dose level serves important tolerability and effectiveness purposes during your transition. Proper storage becomes particularly important during travel or lifestyle changes, with Wegovy's extended room temperature stability offering greater flexibility than your previous Mounjaro routine. Planning your injection schedule around your Mounjaro washout period ensures seamless transition without overlapping medications unnecessarily.
Why Standard Dose Equivalency Charts Don't Apply to Mounjaro-Wegovy Transitions
Traditional pharmaceutical dose conversion charts assume similar mechanisms and metabolic pathways between medications, assumptions that don't hold true for mounjaro to wegovy dose conversion chart applications. Mounjaro's dual receptor agonism creates fundamentally different pharmacological effects compared to Wegovy's single GLP-1 targeting, making mathematical dose equivalencies clinically inappropriate. Most prescribers recommend the restart protocol precisely because attempting dose equivalencies risks either inadequate effectiveness or unnecessary side effects during transition.
This restart approach, while requiring patience through the 16-week escalation, ensures you receive optimal therapeutic benefits from Wegovy's proven dose progression. Your investment in the complete escalation process, from £79.99 monthly initially to £209.99 at maintenance, reflects the clinical reality that effective weight management medications require proper introduction regardless of previous treatments. This mounjaro to wegovy dose conversion chart approach prioritises your long-term success over short-term convenience, ensuring the safest and most effective transition possible.
Securing Your Wegovy Supply with Confidence
Starting your mounjaro to wegovy dose conversion chart journey requires confidence in consistent medication supply throughout the 16-week escalation and beyond. Our FIRST40 discount code for new customers and DOSE25 for returning patients ensure predictable pricing across your entire treatment timeline. EverydayMeds' GPhC-registered pharmacy (#9012878) maintains comprehensive stock levels across all Wegovy doses, preventing treatment interruptions during your critical transition period. Our clinical team provides ongoing support throughout your conversion process, ensuring any questions or concerns receive prompt expert attention. Begin your transition today through our streamlined assessment process at https://everydaymeds.co.uk/collections/wegovy, where transparent pricing and expert clinical support combine to make your weight management journey as smooth as possible.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
